TrialAnnals of oncology : official journal of the European Society for Medical Oncology2012

A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.

A J Zurita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.